The Bottom Line:
Same peptide sequence (GEPPPGKPADDAGLV). The only difference? The salt counterion.
Acetate – conventional, widely studied form
Arginate – paired with arginine instead of acetate
What's Not Different:
- The active peptide is identical
- No peer-reviewed studies show efficacy differences
- Stability claims (e.g., "1,000x more stable") are unverified vendor claims, not published science.
Why Arginate Exists:
After FDA restricted BPC-157, some vendors rebranded the arginate salt as "PDA" to argue it's a new chemical entity. Regulatory experts view this skeptically – the FDA targets the peptide sequence, not the salt.
Key Takeaway:
Same molecule. Different salt. No proven functional difference.